Published in Gastroenterology on February 01, 2010
Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell (2011) 3.36
Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2014) 2.27
Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology (2011) 2.01
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.63
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology (2013) 1.58
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology (2016) 1.52
Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol (2014) 1.16
MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Gastroenterology (2015) 1.01
Ulcerative colitis-associated colorectal cancer. World J Gastroenterol (2014) 0.97
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol (2012) 0.95
Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. World J Gastrointest Endosc (2012) 0.95
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis (2016) 0.93
Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol (2011) 0.93
Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res (2014) 0.93
Automated identification of surveillance colonoscopy in inflammatory bowel disease using natural language processing. Dig Dis Sci (2012) 0.92
Multi-target stool DNA test: a new high bar for noninvasive screening. Dig Dis Sci (2014) 0.91
Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis. Inflamm Bowel Dis (2013) 0.90
Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines. Ann Gastroenterol (2012) 0.90
Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis. World J Gastroenterol (2015) 0.90
The valuable role of endoscopy in inflammatory bowel disease. Diagn Ther Endosc (2012) 0.89
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther (2014) 0.89
Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86
The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch (2014) 0.86
DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis. Dig Dis Sci (2014) 0.85
Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new? World J Gastrointest Endosc (2012) 0.85
Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.84
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am (2014) 0.82
Should chromoendoscopy be the standard of care in ulcerative colitis dysplasia surveillance? Gastroenterol Hepatol (N Y) (2010) 0.81
Highlights of the 48th seminar of korean society of gastrointestinal endoscopy. Clin Endosc (2013) 0.81
Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol (2014) 0.81
Advanced endoscopic imaging for diagnosis of Crohn's disease. Gastroenterol Res Pract (2011) 0.81
Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol (2014) 0.81
Is there a role for prophylactic colectomy in Lynch syndrome patients with inflammatory bowel disease? Int J Colorectal Dis (2015) 0.81
Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease. World J Gastroenterol (2016) 0.81
A case of primary colonic small-cell carcinoma arising in a patient with long-standing ulcerative colitis. Gastrointest Cancer Res (2014) 0.79
Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens. Cancer Res (2015) 0.79
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World J Gastroenterol (2011) 0.79
Chromoendoscopy and Advanced Imaging Technologies for Surveillance of Patients with IBD. Gastroenterol Hepatol (N Y) (2012) 0.79
Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer. PLoS One (2015) 0.78
Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia. Inflamm Bowel Dis (2011) 0.78
DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance. Inflamm Bowel Dis (2016) 0.78
Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. World J Gastroenterol (2015) 0.78
Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol (2013) 0.78
Colorectal Cancer Screening in Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.78
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol (2016) 0.77
Surveillance for colitis-associated colon neoplasia. World J Gastroenterol (2010) 0.77
Quality improvement in gastroenterology clinical practice. Clin Gastroenterol Hepatol (2012) 0.77
Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines. Cancer Lett (2013) 0.77
IBD: role of the pathologist in the diagnosis and management of IBD. Nat Rev Gastroenterol Hepatol (2013) 0.77
Zileuton, 5-lipoxygenase inhibitor, acts as a chemopreventive agent in intestinal polyposis, by modulating polyp and systemic inflammation. PLoS One (2015) 0.77
Trimodal color-fluorescence-polarization endoscopy aided by a tumor selective molecular probe accurately detects flat lesions in colitis-associated cancer. J Biomed Opt (2014) 0.76
Colon cancer screening with image-enhanced endoscopy. Clin Endosc (2014) 0.76
Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view. Therap Adv Gastroenterol (2013) 0.76
Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer. Int J Colorectal Dis (2016) 0.76
Functional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma. PLoS One (2013) 0.76
Control of inflammation by stromal Hedgehog pathway activation restrains colitis. Proc Natl Acad Sci U S A (2016) 0.75
Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management. Cancer Prev Res (Phila) (2016) 0.75
Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis. BMC Surg (2017) 0.75
Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. Cell Mol Gastroenterol Hepatol (2016) 0.75
Clinical usefulness of endoscopic ultrasonography for the evaluation of ulcerative colitis-associated tumors. World J Gastroenterol (2015) 0.75
Surgery in Pediatric Crohn's Disease: Indications, Timing and Post-Operative Management. Pediatr Gastroenterol Hepatol Nutr (2017) 0.75
Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps. Clin Transl Gastroenterol (2015) 0.75
Editorial: Clarity and Caution in the Natural History of Low-Grade Dysplasia in Ulcerative Colitis. Am J Gastroenterol (2015) 0.75
Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future. Gastroenterol Hepatol (N Y) (2015) 0.75
Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol (2016) 0.75
Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis. Dis Markers (2016) 0.75
Infliximab does not increase colonic cancer risk associated to murine chronic colitis. World J Gastroenterol (2016) 0.75
The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies. Cancer Biol Ther (2016) 0.75
Inflammatory Bowel Disease Associated Colorectal Neoplasia. J Gastrointest Dig Syst (2012) 0.75
Rectal cancer: a review. Med J Islam Repub Iran (2015) 0.75
Detection of colorectal dysplasia using fluorescently labelled lectins. Sci Rep (2016) 0.75
Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped? Saudi J Gastroenterol (2014) 0.75
Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol (2015) 0.75
Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study. PLoS One (2017) 0.75
The Role of Chromoendoscopy in Evaluating Colorectal Dysplasia. Gastroenterol Hepatol (N Y) (2017) 0.75
Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: Review of general recommendations. World J Gastrointest Endosc (2017) 0.75
Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis. Clin Transl Oncol (2017) 0.75
Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. World J Gastroenterol (2017) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Intestinal inflammation and cancer. Gastroenterology (2011) 4.13
Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology (2003) 4.10
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Transcolonic endoscopic cholecystectomy: a NOTES survival study in a porcine model (with video). Gastrointest Endosc (2006) 3.32
Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health (2005) 3.28
Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol (2009) 3.18
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2007) 3.00
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol (2005) 2.40
Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2007) 2.39
Cancers complicating inflammatory bowel disease. N Engl J Med (2015) 2.33
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med (2007) 2.23
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.09
Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol (2009) 2.05
Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead? Am J Gastroenterol (2009) 1.93
Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol (2002) 1.79
EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc (2007) 1.70
Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol (2003) 1.66
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61
Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med (2005) 1.55
Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol (2011) 1.50
Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc (2007) 1.47
Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Support Care Cancer (2007) 1.40
Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol (2008) 1.38
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31
Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol (2005) 1.30
Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol (2002) 1.30
Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol (2006) 1.29
Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer (2007) 1.26
A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc (2011) 1.22
Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol (2009) 1.22
Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis (2002) 1.18
Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis (2012) 1.18
Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res (2009) 1.17
KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol (2010) 1.15
Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol (2005) 1.14
Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol (2009) 1.14
Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res (2006) 1.14
Chromosomal instability in Barrett's esophagus is related to telomere shortening. Cancer Epidemiol Biomarkers Prev (2006) 1.12
AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol (2006) 1.09
Culturally targeted patient navigation for increasing african americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2013) 1.09
Inflammatory fibroid polyps of the gastrointestinal tract: evidence for a dendritic cell origin. Am J Surg Pathol (2004) 1.09
Liver disease in the patient with Fontan circulation. Congenit Heart Dis (2011) 1.08
Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus. Hum Pathol (2006) 1.08
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS One (2013) 1.08
Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer (2002) 1.07
Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol (2002) 1.05
Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol (2007) 1.04
Fulminant hepatic failure secondary to erlotinib. Clin Gastroenterol Hepatol (2007) 1.04
Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol (2007) 1.03
Utility of MMP-1, p53, E-cadherin, and collagen IV immunohistochemical stains in the differential diagnosis of adenomas with misplaced epithelium versus adenomas with invasive adenocarcinoma. Am J Surg Pathol (2002) 1.02
Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol (2009) 1.02
Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. Am J Surg Pathol (2007) 1.01
Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol (2004) 1.00
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 0.99
Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.99
IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol (2010) 0.98
NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet (2013) 0.98
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev (2006) 0.98
Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clin Cancer Res (2008) 0.98
Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus. Am J Surg Pathol (2011) 0.98
Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients. Histopathology (2011) 0.97
Endoscopic mucosal tissue sampling. Gastrointest Endosc (2013) 0.95
Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol (2005) 0.95
Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol (2008) 0.94
Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol (2007) 0.94
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2009) 0.94
Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94
Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol Clin North Am (2007) 0.93
N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer (2010) 0.93
The molecular and genetic basis of colon cancer. Med Clin North Am (2002) 0.93
Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol (2006) 0.93
Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol (2009) 0.92
Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities. Cancer (2012) 0.92
Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway. Hum Pathol (2009) 0.91
Eosinophilic esophagitis without abundant eosinophils? The expanding spectrum of a disease that is difficult to define. Dig Dis Sci (2011) 0.91
Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol (2010) 0.91
Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol (2002) 0.91
MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Am J Surg Pathol (2011) 0.91
Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev (2005) 0.90
Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer (2014) 0.89
Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis. Am J Surg Pathol (2013) 0.89
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer (2008) 0.89
Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2007) 0.89
Effect of comorbid conditions on adherence to colorectal cancer screening. J Cancer Educ (2012) 0.89
Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma. Gastroenterol Clin North Am (2007) 0.89
Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol (2004) 0.89
DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions. Am J Surg Pathol (2008) 0.88
Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol (2016) 0.88
A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. Am J Surg Pathol (2007) 0.88
p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One (2008) 0.87
An unusual mixed tumor of the pancreas: sonographic and MDCT features. JOP (2009) 0.86
Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis (2003) 0.85